These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2339673)

  • 1. Cyclophosphamide and 15(S)-15 methyl PGE1 correct the T/B lymphocyte ratios of NZB/NZW mice.
    Girard D; Aloisi RM; Bliven ML; Cunningham AC; Otterness IG
    Agents Actions; 1990 Mar; 29(3-4):333-41. PubMed ID: 2339673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition.
    Schiffer L; Sinha J; Wang X; Huang W; von Gersdorff G; Schiffer M; Madaio MP; Davidson A
    J Immunol; 2003 Jul; 171(1):489-97. PubMed ID: 12817034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
    Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
    Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
    Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice.
    Sun D; Krishnan A; Su J; Lawrence R; Zaman K; Fernandes G
    Cell Immunol; 2004 Mar; 228(1):54-65. PubMed ID: 15203320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.
    Zoja C; Casiraghi F; Conti S; Corna D; Rottoli D; Cavinato RA; Remuzzi G; Benigni A
    Arthritis Rheum; 2007 May; 56(5):1629-37. PubMed ID: 17469145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice.
    Sekigawa I; Okada T; Noguchi K; Ueda G; Hirose S; Sato H; Shirai T
    J Immunol; 1987 May; 138(9):2890-5. PubMed ID: 2952727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic studies in NZB/NZW F1 mice. V. Comparison of cyclophosphamide and chlorambucil.
    Gerber NL; Powell D; Steinberg AD
    Arthritis Rheum; 1977; 20(6):1263-8. PubMed ID: 901598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice.
    Gu F; Molano I; Ruiz P; Sun L; Gilkeson GS
    Clin Immunol; 2012 Nov; 145(2):142-52. PubMed ID: 23041504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of NZB/W ("lupus") mice with 15(S)-15 methyl PGE1.
    Zurier RB; Gionfriddo M; Miller P
    Prostaglandins Med; 1980 Apr; 4(4):281-4. PubMed ID: 7394067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice.
    Ono S; Shao D; Yamada S; Yang Y; Yamashita M; Hamaoka T
    Immunology; 2000 May; 100(1):99-109. PubMed ID: 10809965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB x NZW)F1 mice.
    Hirose S; Tokushige K; Kinoshita K; Nozawa S; Saito J; Nishimura H; Shirai T
    Eur J Immunol; 1991 Mar; 21(3):823-6. PubMed ID: 1826267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice.
    Bignon A; Gaudin F; Hémon P; Tharinger H; Mayol K; Walzer T; Loetscher P; Peuchmaur M; Berrebi D; Balabanian K
    J Immunol; 2014 Feb; 192(3):886-96. PubMed ID: 24367031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals.
    Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T
    J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus.
    Ebling FM; Tsao BP; Singh RR; Sercarz E; Hahn BH
    Arthritis Rheum; 1993 Mar; 36(3):355-64. PubMed ID: 7680861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.
    Graham KL; Lee LY; Higgins JP; Steinman L; Utz PJ; Ho PP
    Autoimmunity; 2010 Mar; 43(2):140-55. PubMed ID: 19845477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of NZB/NZW mice with total lymphoid irradiation: long-lasting suppression of disease without generalized immune suppression.
    Kotzin BL; Arndt R; Okada S; Ward R; Thach AB; Strober S
    J Immunol; 1986 May; 136(9):3259-65. PubMed ID: 2937842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.
    Reininger L; Winkler TH; Kalberer CP; Jourdan M; Melchers F; Rolink AG
    J Exp Med; 1996 Sep; 184(3):853-61. PubMed ID: 9064345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.